The power of mass cytometry to advance COVID-19 research
The COVID-19 public health crisis affects everyone in our global community, and crucial questions about how SARS-CoV-2 affects our immune system need to be answered.
High-parameter mass cytometry can be a critical tool for deep immune profiling of COVID-19 patients, allowing researchers to examine a variety of immune cell types at single-cell resolution while also assessing functional markers.
The Maxpar® Direct™ Immune Profiling System is ideally suited to this task.
The system identifies phenotypic and functional changes in 37 cell populations in a single tube, using the ready-made 30-marker backbone panel. Get deeper insights by adding more antibodies to customize the assay and answer your unique research questions.
To learn more about the use of mass cytometry in COVID19 research, please register for the upcoming coronavirus webseries.